Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Nanocarrier (4571 JP)
Watchlist
6
Analysis
Health Care
•
Japan
NanoCarrier Co., Ltd. is a biotech company that utilizes micellar nanoparticle (polymeric micelles) technology for the production and development of pharmaceuticals focusing mainly on cancer therapies.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Nanocarrier
•
13 Aug 2024 10:03
•
Issuer-paid
Nanocarrier (4571 JP): Q1 FY03/25 flash update
The company reported no sales in Q2 FY03/23, with operating and recurring losses narrowing YoY due to decreased SG&A expenses. The company...
Shared Research
Follow
163 Views
Share
bullish
•
MSCI ACWI Index
•
27 Jul 2018 02:23
Global Strategy: Health Care Outperforming - Overweight; India Breaking Out -Add Exposure
Today's report puts a spotlight on the Health Care Sector, which is assuming a global leadership role vs. other Sectors. We also focus on...
Vermilion Research
Follow
528 Views
Share
bullish
•
Medrx Co Ltd
•
16 Apr 2017 18:50
Medrx - Japan Biotech Microcap in Potential Big Licensing Deal
Although the Japanese drug industry suffers from a lack of scale, where it is good is in applying manufacturing techniques to develop not just...
Pelham Smithers Associates
431 Views
Share
bullish
•
Peptidream Inc
•
11 Apr 2017 21:53
PeptiDream: J&J Latest Drug Major to Tie Up
On the surface, Peptidream's (4587 JP) deal with Johnson & Johnson's (JNJ US) Janssen unit looks no different from the deals they have cut with...
Pelham Smithers Associates
342 Views
Share
bullish
•
Kyowa Kirin Co Ltd
•
10 Apr 2017 16:15
Sosei & Kyowa Hakko Kirin: Positive News on GPCR Drugs
Kyowa Hakko Kirin's (4151 JP) announcement that “moga” – mogamulizumab (KW-0761) – has met its primary endpoint (PFS) in Phase III trials for...
Pelham Smithers Associates
290 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.35.0
x